Literature DB >> 25296998

Protective effects of n-6 fatty acids-enriched diet on intestinal ischaemia/reperfusion injury involve lipoxin A4 and its receptor.

T Gobbetti1, S Ducheix, P le Faouder, T Perez, F Riols, J Boue, J Bertrand-Michel, M Dubourdeau, H Guillou, M Perretti, N Vergnolle, N Cenac.   

Abstract

BACKGROUND AND
PURPOSE: Long-term intake of dietary fatty acids is known to predispose to chronic inflammation, but their effects on acute intestinal ischaemia/reperfusion (I/R) injury is unknown. The aim of this study was to determine the consequences of a diet rich in n-3 or n-6 polyunsaturated fatty acids (PUFA) on intestinal I/R-induced damage. EXPERIMENTAL APPROACH: Mice were fed three different isocaloric diets: a balanced diet used as a control and two different PUFA-enriched diets, providing either high levels of n-3 or of n-6 PUFA. Intestinal injury was evaluated after intestinal I/R. PUFA metabolites were quantitated in intestinal tissues by LC-MS/MS. KEY
RESULTS: In control diet-fed mice, intestinal I/R caused inflammation and increased COX and lipoxygenase-derived metabolites compared with sham-operated animals. Lipoxin A4 (LxA4 ) was significantly and selectively increased after ischaemia. Animals fed a high n-3 diet did not display a different inflammatory profile following intestinal I/R compared with control diet-fed animals. In contrast, intestinal inflammation was decreased in the I/R group fed with high n-6 diet and level of LxA4 was increased post-ischaemia compared with control diet-fed mice. Blockade of the LxA4 receptor (Fpr2), prevented the anti-inflammatory effects associated with the n-6 rich diet. CONCLUSIONS AND IMPLICATIONS: This study indicates that high levels of dietary n-6, but not n-3, PUFAs provides significant protection against intestinal I/R-induced damage and demonstrates that the endogenous production of LxA4 can be influenced by diet.
© 2014 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25296998      PMCID: PMC4301698          DOI: 10.1111/bph.12957

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  56 in total

1.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 2.  Lipoxins: revelations on resolution.

Authors:  B McMahon; S Mitchell; H R Brady; C Godson
Journal:  Trends Pharmacol Sci       Date:  2001-08       Impact factor: 14.819

Review 3.  Lipoxins: a new series of eicosanoids (biosynthesis, stereochemistry, and biological activities).

Authors:  C N Serhan; B Samuelsson
Journal:  Adv Exp Med Biol       Date:  1988       Impact factor: 2.622

4.  Lateral membrane LXA4 receptors mediate LXA4's anti-inflammatory actions on intestinal epithelium.

Authors:  Torsten Kucharzik; Andrew T Gewirtz; Didier Merlin; James L Madara; Ifor R Williams
Journal:  Am J Physiol Cell Physiol       Date:  2002-11-27       Impact factor: 4.249

5.  Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes.

Authors:  C N Serhan; M Hamberg; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

6.  Increased phospholipase A2 and decreased lysophospholipase activity in the small intestinal mucosa after ischaemia and revascularisation.

Authors:  T Otamiri; L Franzén; D Lindmark; C Tagesson
Journal:  Gut       Date:  1987-11       Impact factor: 23.059

7.  A vasculo-protective circuit centered on lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 operative in murine microcirculation.

Authors:  Vincenzo Brancaleone; Thomas Gobbetti; Nicolas Cenac; Pauline le Faouder; Bartomeu Colom; Roderick J Flower; Nathalie Vergnolle; Sussan Nourshargh; Mauro Perretti
Journal:  Blood       Date:  2013-06-03       Impact factor: 22.113

8.  Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration.

Authors:  Gerard Bannenberg; Rose-Laure Moussignac; Karsten Gronert; Pallavi R Devchand; Birgitta A Schmidt; William J Guilford; John G Bauman; Babu Subramanyam; H Daniel Perez; John F Parkinson; Charles N Serhan
Journal:  Br J Pharmacol       Date:  2004-08-09       Impact factor: 8.739

9.  The Concise Guide to PHARMACOLOGY 2013/14: enzymes.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

10.  The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands.

Authors:  Adam J Pawson; Joanna L Sharman; Helen E Benson; Elena Faccenda; Stephen P H Alexander; O Peter Buneman; Anthony P Davenport; John C McGrath; John A Peters; Christopher Southan; Michael Spedding; Wenyuan Yu; Anthony J Harmar
Journal:  Nucleic Acids Res       Date:  2013-11-14       Impact factor: 16.971

View more
  15 in total

1.  Formyl peptide receptor 1 suppresses gastric cancer angiogenesis and growth by exploiting inflammation resolution pathways.

Authors:  Nella Prevete; Federica Liotti; Anna Illiano; Angela Amoresano; Piero Pucci; Amato de Paulis; Rosa Marina Melillo
Journal:  Oncoimmunology       Date:  2017-02-21       Impact factor: 8.110

Review 2.  Special pro-resolving mediator (SPM) actions in regulating gastro-intestinal inflammation and gut mucosal immune responses.

Authors:  Ruth X Wang; Sean P Colgan
Journal:  Mol Aspects Med       Date:  2017-02-21

Review 3.  Pro- and anti-inflammatory bioactive lipids imbalance contributes to the pathobiology of autoimmune diseases.

Authors:  Undurti N Das
Journal:  Eur J Clin Nutr       Date:  2022-06-14       Impact factor: 4.016

4.  Pre-clinical effects of metformin and aspirin on the cell lines of different breast cancer subtypes.

Authors:  Maria Eduarda Azambuja Amaral; Laura Roesler Nery; Carlos Eduardo Leite; Walter Filgueira de Azevedo Junior; Maria Martha Campos
Journal:  Invest New Drugs       Date:  2018-02-02       Impact factor: 3.850

Review 5.  Eicosanoids in the gastrointestinal tract.

Authors:  John L Wallace
Journal:  Br J Pharmacol       Date:  2018-04-16       Impact factor: 8.739

6.  Protective effect of soybean oil- or fish oil-rich diets on allergic airway inflammation.

Authors:  Roberta Araujo Navarro-Xavier; Karina Vieira de Barros; Iracema Senna de Andrade; Zaira Palomino; Dulce Elena Casarini; Vera Lucia Flor Silveira
Journal:  J Inflamm Res       Date:  2016-05-19

7.  Thrombin modifies growth, proliferation and apoptosis of human colon organoids: a protease-activated receptor 1- and protease-activated receptor 4-dependent mechanism.

Authors:  Morgane Sébert; Alexandre Denadai-Souza; Muriel Quaranta; Claire Racaud-Sultan; Sophie Chabot; Philippe Lluel; Nicolas Monjotin; Laurent Alric; Guillaume Portier; Sylvain Kirzin; Delphine Bonnet; Audrey Ferrand; Nathalie Vergnolle
Journal:  Br J Pharmacol       Date:  2018-08-07       Impact factor: 8.739

8.  Identification of specialized pro-resolving mediator clusters from healthy adults after intravenous low-dose endotoxin and omega-3 supplementation: a methodological validation.

Authors:  Paul C Norris; Ann C Skulas-Ray; Ian Riley; Chesney K Richter; Penny M Kris-Etherton; Gordon L Jensen; Charles N Serhan; Krishna Rao Maddipati
Journal:  Sci Rep       Date:  2018-12-21       Impact factor: 4.379

9.  Effects of n-3 PUFAs on Intestinal Mucosa Innate Immunity and Intestinal Microbiota in Mice after Hemorrhagic Shock Resuscitation.

Authors:  Feng Tian; Xuejin Gao; Li Zhang; Xinying Wang; Xiao Wan; Tingting Jiang; Chao Wu; Jingcheng Bi; Qiucheng Lei
Journal:  Nutrients       Date:  2016-09-29       Impact factor: 5.717

Review 10.  Breast Milk Lipids and Fatty Acids in Regulating Neonatal Intestinal Development and Protecting against Intestinal Injury.

Authors:  David Ramiro-Cortijo; Pratibha Singh; Yan Liu; Esli Medina-Morales; William Yakah; Steven D Freedman; Camilia R Martin
Journal:  Nutrients       Date:  2020-02-19       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.